03/02/2026
🚨 177Lu-PSMA Therapy & Imaging in Prostate Cancer
• PSMA-PET/CT guides patient selection & tracks response
• Adjuncts like 18F-FDG PET, post-therapy SPECT, & whole-body DWI-MRI catch resistant/PSMA-negative disease
• Quantitative biomarkers (SUVmean, tumor volume, heterogeneity) + AI/radiomics may personalize treatment
https://link.springer.com/article/10.1186/s13244-025-02151-x (Aditi Ranjan et al.)